| May 11, 2023 |
”MEDI LINX OPENS FIRST STANDALONE CLINICAL LABORATORY IN QUEZON CITY” |
| February 17, 2023 |
”NEW LABORATORY: MEDI LINX QUEZON CITY LABORATORY'S SERVICE OFFERINGS” |
| August 5, 2022 |
”NEW TEST ITEM: ProGRP” |
| July 18, 2022 |
”NEW TEST ITEM: BACTERIAL CULTURE AND SENSITIVITY” |
| July 18, 2022 |
”NEW TEST ITEM: MYCOBACTERIAL SUSCEPTIBILITY” |
| July 18, 2022 |
”NEW TEST ITEM: MYCOBACTERIAL CULTURE” |
| July 18, 2022 |
”NEW TEST ITEM: YEAST SENSITIVITY (MICRODILUTION)” |
| June 29, 2022 |
”MEDI LINX LABORATORY INC. ACCELERATES EXPANSION PLANS, INAUGURATES NEW CORPORATE OFFICE” |
| June 7, 2022 |
”Role of IGRA Test on Diagnosis and Treatment of Tuberculosis” |
| May 30, 2022 |
”NEW TEST ITEM: ANTI BETA 2 GLYCOPROTEIN IGG” |
| May 30, 2022 |
”NEW TEST ITEM: ANTI BETA 2 GLYCOPROTEIN IGM” |
| May 30, 2022 |
”NEW TEST ITEM: KIDNEY STONE ANALYSIS” |
| April 26, 2022 |
”NEW TEST ITEM: MTB HIGH CONCENTRATION DRUG SUSCEPTIBILITY” |
| March 30, 2022 |
”Allergy Testing : What we Need to Know” |
| March 17, 2022 |
MLLI WEBINAR: 3-PART WEBINAR SERIES: FUNDAMENTALS OF CLINICAL HEMATOLOGY, HEMOSTASIS, AND URINALYSIS PART III: ADVANCES IN URINALYSIS PARAMETERS: RBC MORPHOLOGY “THE (W)HOLE STORY OF THE DOUGHNUT IN URINE” |
| January 21, 2022 |
Good Clinical Laboratory Practice in Tuberculosis Culture & Drug Susceptibility Testing: An Insight at the National TB Reference Laboratory |
| January 19, 2022 |
NEW TEST ITEM: SARS-COV-2 NEUTRALIZING AB |
| December 2, 2021 |
MLLI WEBINAR: PIONEERING DIAGNOSTICS: THE NEW FULLY AUTOMATED INTERFERON-GAMMA RELEASE ASSAY (IGRA) TEST FOR TUBERCULOSIS INFECTION. |
| October 14, 2021 |
MLLI WEBINAR: 3-Part Webinar Series: Fundamentals of Clinical Hematology, Hemostasis, and Urinalysis |
| September 30, 2021 |
NEW TEST ITEM: Sputum Culture and Sensitivity |
| September 30, 2021 |
NEW TEST ITEM: Fecal Immunochemical Test (FIT) |
| September 30, 2021 |
NEW TEST ITEM: UROGENITAL CULTURE PANEL |
| September 30, 2021 |
NEW TEST ITEM: STERILE BODY FLUID PANEL |
| September 30, 2021 |
NEW TEST ITEM: BACTERIAL CULTURE PANEL |
| September 3, 2021 |
NEW TEST ITEM: 24 HOUR URINE SEROTONIN (5HIAA) |
| August 27, 2021 |
MLLI WEBINAR: The Importance of Blood Culture & Sensitivity, Minimum Inhibitory Concentration & Filamentous Fungi Identification in Patient Management |
| August 16, 2021 |
MLLI WEBINAR: THE ROLE OF INTERFERON-GAMMA RELEASE ASSAYS IN FINDlNG LATENT TUBERCULOSIS INFECTION AMONG HIGH-RISK GROUP |
| July 21, 2021 |
MLLI WEBINAR: CLINICAL UTILITY OF BIOFIRE PANEL IN MANAGING MENINGITIS, ENCEPHALITIS AND GASTROINTESTINAL INFECTIONS. |
| July 15, 2021 |
NEW TEST ITEM: HCV VIRAL LOAD |
| June 23, 2021 |
MLLI WEBINAR: UNDERSTANDING SERUM PROTEIN ELECTROPHORESIS TEST USING CAPILLARY ELECTROPHORESIS TECHNOLOGY |
| April 01, 2021 |
NEWSLETTER - PRESEPSIN |
| March 25, 2021 |
NEWSLETTER - MENINGITIS PANEL |
| March 22, 2021 |
NEWSLETTER - PIVKA II |
| March 18, 2021 |
NEWSLETTER - GASTROINTESTINAL PANEL |
| March 16, 2021 |
MLLI WEBINAR: CAPILLARY ELECTROPHORESIS TEST (HEMOGLOBIN) |
| March 15, 2021 |
NEWSLETTER - RESPIRATORY PANEL |
| March 11, 2021 |
NEWSLETTER - INTERLEUKIN - 6 |
| March 08, 2021 |
NEWSLETTER - CARDIAC TROPONIN T |
| March 04, 2021 |
NEWSLETTER - ANTI NUCLEAR ANTIBODY |
| March 01, 2021 |
NEWSLETTER - INFLUENZA A&B PCR TEST |
| February 18, 2021 |
MLLI WEBINAR: ACUTE KIDNEY INJURY IN COVID-19: THE NEED FOR EARLY RECOGNITION |
| October 28, 2020 |
MLLI WEBINAR: THE IMPORTANCE OF SEROLOGY TEST FOR SARS COV2 DIAGNOSIS |
| October 9, 2020 |
MLLI WEBINAR: HOST RESPONSE AND THE CLINICAL APPLICATION OF ASSOCIATED BIOMARKERS IN COVID-19 |
| October 8, 2020 |
NEW TEST ITEM: CYSTATIN C |
| October 5, 2020 |
MLLI WEBINAR: CARDIAC TROPONIN T BIOMARKER UPDATE |
| August 14, 2020 |
NEW TEST ITEM: INTERLEUKIN-6 |
| August 14, 2020 |
MLLI WEBINAR: P- SEP |
| July 27, 2020 |
NEW TEST ITEM: SARS-COV-2 IgG |
| April 9, 2020 |
ANNOUNCEMENT |
| February 01, 2020 |
MEDI LINX WEBSITE LAUNCH |
